Bioverativ Inc. is an American multinational biotechnology company that specializes in the discovery, development, and delivery of therapies for the treatment of hemophilia. The company trades on the NASDAQ exchange under the ticker symbol BIVV until Sanofi completed its acquisition.
Fully owned subsidiary of Source Consulting LLC ©2024 SharePoint Geeks. All rights reserved.